US Patent Issued to Ophirex on Aug. 12 for "PLA2 inhibitors for treatment of pathological conditions caused by hymenoptera envenomation, such as hemolysis, cerebral edema, and acute kidney injury" (California Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,531, issued on Aug. 12, was assigned to Ophirex Inc. (Corte Madera, Calif.).

"PLA2 inhibitors for treatment of pathological conditions caused by hymenoptera envenomation, such as hemolysis, cerebral edema, and acute kidney injury" was invented by Matthew R. Lewin (Corte Madera, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for treatment of pathological conditions causing hemolysis, cerebral edema, acute kidney injury and non-anaphylactic shock, including envenomation, trauma, cerebral malaria and mast-cell diseases using at least one PLA2 inhibitor, alone or in combination with other agents. The unexpected versatility of...